Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Parkinsonism Relat Disord ; 89: 199-205, 2021 08.
Article in English | MEDLINE | ID: covidwho-1300965


The use of telemedicine in the management of chronic neurological conditions including movement disorders has expanded over time. In addition to enabling remote access to specialized care, telemedicine has also been shown to reduce caregiver burden and to improve patient satisfaction. With the COVID-19 pandemic, implementation of telehealth for patients with movement disorders, particularly those with more severe mobility issues, has increased rapidly. Although telemedicine care has been shown to be effective for patients with various movement disorders, its utilization for patients with device aided therapies such as deep brain stimulation (DBS) is limited due to challenges related to adjusting these devices remotely and to the lack of consensus recommendations for using telemedicine in this patient population. Thus, guidelines for telemedicine and DBS will assist clinicians on the appropriate implementation of telemedicine to provide care to DBS patients. Optimizing the use of telemedicine for DBS will expand this type of therapy to remote locations with limited access to programming expertise, and also reduce the need for patient travel. Telemedicine is particularly important during the ongoing pandemic due to infection risk and limited access to clinic visits. In this article we review the currently available and emerging strategies for telemedicine and remote care for DBS. We then outline common principles and recommendations for telemedicine care in patients with DBS, review patient selection and best practices. Finally, we briefly discuss the current state of reimbursement for DBS telemedicine visits.

Deep Brain Stimulation/trends , Telemedicine/trends , COVID-19 , Deep Brain Stimulation/standards , Humans , Pandemics , Remote Consultation , Telemedicine/standards
Parkinsonism Relat Disord ; 86: 135-138, 2021 05.
Article in English | MEDLINE | ID: covidwho-1230072


The evaluation and management of patients with movement disorders has evolved considerably due to the COVID-19 pandemic, including the assessment of candidates for deep brain stimulation (DBS) therapy. Members of the Neuropsychology Focus Group from the Parkinson Study Group Functional Neurosurgical Working Group met virtually to discuss current practices and solutions, build consensus, and to inform the DBS team and community regarding the complexities of performing DBS neuropsychological evaluations during COVID-19. It is our viewpoint that the practice of neuropsychology has adapted successfully to provide tele-neuropsychological pre-DBS evaluations during the global pandemic, thus permanently changing the landscape of neuropsychological services.

COVID-19 , Deep Brain Stimulation/trends , Movement Disorders/psychology , Movement Disorders/surgery , Neuropsychological Tests , Neuropsychology/trends , Neurosurgery/trends , Pandemics , Parkinson Disease/psychology , Parkinson Disease/surgery , Deep Brain Stimulation/statistics & numerical data , Humans , Telemedicine